Skip to main content
BMJ Open logoLink to BMJ Open
. 2024 Oct 16;14(10):e091378. doi: 10.1136/bmjopen-2024-091378

Cross-disciplinary working between gynaecologists and mental healthcare professionals: a mixed-methods systematic review protocol

Yvonne Hartnett 1,2,, Rebecca Conlan-Trant 3, Richard Duffy 1,4,0, Anne M Doherty 1,5,0
PMCID: PMC11535760  PMID: 39414291

Abstract

Abstract

Introduction

Reproductive hormone transitions (menstrual cycle, post partum and menopause) can trigger mental disorders in a subset of women. Gynaecological diseases, such as endometriosis and polycystic ovary syndrome, can also elevate the risk of mental illness. The link between psychiatrists and obstetricians is already well established in the peripartum period; however, the link between gynaecology and psychiatry is less so. This mixed-methods systematic review aims to synthesise the existing evidence for integrated mental healthcare for gynaecological illnesses or reproductive hormone transitions outside the perinatal period.

Methods and analysis

A systematic search of the MEDLINE, Embase, Scopus, PsycInfo, CINAHL and Web of Science databases will be conducted. All study types will be considered, both quantitative and qualitative. Opinion and expert consensus statements, as well as government and professional body documents, will also be included, but separately analysed and reported. Studies examining the unmet clinical needs and experiences of women experiencing mental disorders related to reproductive hormone transitions (menarche, menstrual, menopause, but not pregnancy or breast feeding) or gynaecological illness will be included. Studies related to the experience or training of professionals caring for them will be included, specifically on the concept of integrated or interdisciplinary work with colleagues outside their specialty. Abstracts of the identified papers will be screened independently by two reviewers. Full texts will be assessed by two reviewers, and data will be extracted using predetermined data extraction tools. Quantitative studies will be synthesised in narrative format. A thematic synthesis of qualitative studies will be conducted and an integrated narrative synthesis will be described.

Ethics and dissemination

Ethical approval is not required for this systematic review, as no primary data will be collected. The results will be disseminated via a peer-reviewed publication in a relevant scientific journal.

PROSPERO registration number

CRD42024523590.

Keywords: delivery of health care, integrated; psychiatry; gynaecology


Strengths and limitations of this study.

  • This is the first systematic review examining integrated mental healthcare in gynaecology settings and in non-pregnancy-related reproductive transitions.

  • The synthesis of quantitative and qualitative evidence will provide a comprehensive picture of what is currently known about this topic.

  • The selection, appraisal and synthesis of studies will be conducted by two reviewers.

  • This systematic review protocol is prepared in line with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols statement and is prospectively registered.

  • The restriction to English-language publications will limit the generalisability of the findings.

Introduction

Rationale

The WHO has stated that ‘the focus on hospital-based, disease-based and self-contained ‘silo’ curative care models undermines the ability of health systems to provide universal, equitable, high-quality and financially sustainable care’.1 In Ireland, the Sláintecare and Sharing the Vision reports have incorporated this view and promote greater integration of care between physical and mental healthcare.2 3

Women are seeking greater cooperation between gynaecologists and mental health professionals and improved understanding of the impact of hormonal transitions and gynaecological symptoms on their mental health, particularly in relation to premenstrual dysphoric disorder, menopause, and endometriosis.4

There are high rates of comorbidity between gynaecological and female reproductive system disorders.5 Many common gynaecological conditions are associated with psychological or psychiatric disturbances and impaired quality of life, including endometriosis,6,18 polycystic ovarian syndrome,19,32 adenomyosis,33 and chronic pelvic pain.34,38 There is a well-established link between depression and pain.39

Normal reproductive events also predispose women to psychiatric symptoms, with an increased rate of depression during perimenopause.40,44 Premenstrual disorders are a particular area where closer collaboration is needed between gynaecologists and psychiatry (or mental health professionals more widely), given that the assessment and treatment span both specialties. Premenstrual dysphoric disorder was incorporated into the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013,45 46 and has a prevalence of at least 5% among women of reproductive age.47 Treatments include selective serotonin reuptake inhibitors, drospirenone-containing combined oral contraceptives, and in severe cases, the use of gonadotropin hormone-releasing hormone analogues and bilateral salpingo-oophorectomy with hysterectomy.48 It can be difficult to differentiate premenstrual dysphoric disorder from premenstrual exacerbations of pre-existing mental illnesses.49 There is also an association between premenstrual dysphoric symptoms and suicidal thoughts and behaviours independent of psychiatric comorbidity.50,52 Interdisciplinary work between the two specialties is essential to ensure accurate diagnosis and appropriate management of complex cases.

The impact of maternal mental illness during pregnancy on both mothers and infants has been established.53,55 This is reflected in the recent development of perinatal mental health services in the UK56 and Ireland,57 and there are robust calls for improved access to these services in Australia, New Zealand,58 the USA59 and Canada.60 While this is an emerging area of healthcare delivery, integration of mental healthcare into obstetric settings appears to be effective,61 62 though further work is needed to determine the most effective service model.63 Given the expanse of active research on mental health in the perinatal period, this review will only consider non-pregnancy-related reproductive transitions and gynaecological illnesses.

Objectives

The objective of this mixed-methods systematic review is to synthesise the current evidence base for integrated working between mental health professionals and gynaecologists to inform clinical practice, service delivery and public policy. Given the multifaceted nature of the available evidence, a synthesis of both qualitative and quantitative evidence is necessary.

  1. What is the evidence for the clinical need and effectiveness of integrated mental healthcare in non-pregnancy-related reproductive hormone transitions and gynaecological illness, and how has this been implemented? (Quantitative component).

  2. What are the experiences, attitudes and perceptions of patients and professionals regarding the assessment and treatment of mental health conditions associated with non-pregnancy-related reproductive hormone transitions and gynaecological illnesses? What are the barriers and facilitators of this? (Qualitative component)

Methods and analysis

Design

The Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) were used in the preparation of this protocol64 (see online supplemental appendix 1) and will be reported in accordance with the PRISMA-2020 statement,65 the Enhancing Transparency in Reporting the Synthesis of Qualitative Research (ENTREQ) statement66 and the guideline for Synthesis Without Meta-analysis (SWiM) items.67 This protocol is informed by the Joanna Briggs Institute (JBI) guidance for mixed-methods systematic reviews.68

The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 23 March 2024 (CRD42024523590).69

Eligibility criteria

Population

This review will consider studies that relate to women or those assigned female at birth experiencing mental illness associated with gynaecological disorders or reproductive transitions of menarche, menstruation and menopause, but not pregnancy-related reproductive transitions. Women’s mental health outside of these circumstances will be out of the scope of this review. Healthcare professionals in the field of mental health or gynaecology working with these patient groups will also be included.

Concept of interest

The design and delivery of integrated healthcare, interdisciplinary collaboration between mental health professionals of any kind and gynaecologists and cross-disciplinary training will be examined in this review. Papers describing the impact of a lack of integration will also be included.

Outcomes

The quantitative component of this review will consider studies that include the following outcome measures: quality of care, access to diagnosis and treatment, diagnostic delay, or misdiagnosis.

Views, perceptions, opinions and experiences of patients/service users, carers, or any healthcare professionals regarding the diagnosis and treatment of these conditions will be explored through the qualitative component.

Context

Any physical or mental healthcare setting, including gynaecology and primary care women’s health services, as well as postgraduate or specialty medical training. Studies in mixed obstetric and gynaecological populations will be included only if gynaecological outcomes are reported separately.

Study design

As the literature on this topic is limited, all study types (quantitative, qualitative or mixed methods) will be considered for inclusion. Reviews, opinion papers, editorials, expert consensus, government reports and clinical guidelines will also be included. Only papers published in English or with an English translation will be included. No time limits will apply to allow in order to report on the evolution of clinical practice and theories on the relationship between mental health and the female reproductive system over time.

Information sources

The following electronic databases will be searched: MEDLINE, CINAHL, Embase, Scopus, PsycInfo and Web of Science. The search strategy was developed with the assistance of a medical librarian using medical subject heading terms and keywords identified through an initial exploratory search. The search strategy for MEDLINE is included in online supplemental appendix 2. This will be adapted for each database. The reference lists of the included articles will be hand searched for additional studies.

Hand searches of the websites of relevant professional, government and non-government organisations in English-speaking countries for grey literature will be completed, including the Royal College of Obstetricians & Gynaecologists, the American College of Obstetricians & Gynecologists, the Royal Australian & New Zealand College of Obstetricians & Gynaecologists, The Society of Obstetricians and Gynaecologists of Canada, the Royal College of Psychiatrists, American Psychiatric Association, the Royal Australian and New Zealand College of Psychiatrists, the Canadian Psychiatric Association, the International Association for Premenstrual Disorders, the International Society for Psychosomatic Obstetrics & Gynaecology, and the International Menopause Society.

Study records

Data management

References will be imported into Endnote software,70 and duplicates will be removed. This list will then be uploaded to the Covidence web application71 for study selection process.

Selection process

Title and abstract screening will be completed independently by two reviewers (YH and RC-T), and full texts will be retrieved for these papers. The full texts will be assessed against the inclusion and exclusion criteria by the same two reviewers independently, with a third reviewer resolving disagreements. The selection process will be documented in a PRISMA flow diagram. The reasons for the exclusion of full texts will be reported.

Data extraction

Quantitative and qualitative data will be independently extracted by two reviewers (YH and RC-T) and input into Microsoft Excel. This process will be validated by a third reviewer.

A data extraction form will be used to collect the following data from quantitative studies:

  1. Title, author, year of publication and journal

  2. Research aim

  3. Setting

  4. Methodology

  5. Participant characteristics

  6. Intervention: the Template for Intervention Description and Replication (TIDieR) checklist will be used for any intervention characteristics.72

  7. Assessment tools used

  8. Results

  9. Conclusions

  10. Strengths and limitations

The JBI ‘QARI Qualitative data extraction tool’ will be used to extract data from qualitative studies.73 Data from the results and discussion sections of qualitative studies or qualitative components of mixed-methods studies will be imported into NVivo74 for analysis. The JBI ‘Textual data extraction form for text and opinion publications’ will be used to extract data from opinion papers.75

Quality appraisal

Quality appraisal will be conducted independently by two reviewers (YH and RC-T), and a third reviewer will resolve disagreements. The appraisal tools used will depend on the study design in question. Observational studies will be assessed using the ‘Risk Of Bias In Non-randomised Studies-of Exposures’ (ROBINS-E) tool.76 It is not anticipated that there will be any randomised controlled trials, but if any are found, they will be assessed using the Cochrane risk of bias tool for randomised trials (RoB-2).77

Qualitative studies will be subjected to both the Critical Appraisal Skills Programme (CASP) checklist for qualitative studies78 and the JBI ‘Critical Appraisal Checklist for Qualitative Research’.73 There is the lack of consensus on a preferred tool for appraising qualitative studies, or even consensus on whether qualitative studies can be critically appraised. Using two differing tools will allow different aspects of included studies to be examined. The JBI ‘Critical Appraisal Checklist for Text and Opinion Papers’75 will be used for opinion articles and grey literature will be appraised using the ‘Authority, Accuracy, Coverage, Objectivity, Date, Significance’ checklist.79 The results of the quality appraisal will be reported in narrative and tabular format in the final manuscript.

Data synthesis

The data synthesis will follow a convergent segregated design in line with the JBI methodology,68 where quantitative and qualitative data are synthesised separately before being integrated.

Synthesis of quantitative data

Based on an exploratory search of the literature, the heterogeneity of quantitative studies is anticipated to be high and will likely preclude meta-analysis. If included papers allow for meta-analysis, a random effects model will be used with evaluation of heterogeneity and publication bias via I2, funnel plots and Egger test. The data will be presented in tabular form, and a narrative synthesis will be employed to provide a descriptive summary of the quantitative studies. The SWiM guidance will be used where a meta-analysis is not possible.67

Synthesis of qualitative data

Qualitative data will be synthesised using inductive thematic analysis using the methodology described by Thomas and Harden.80 This was selected as a flexible synthesis strategy that is appropriate to healthcare research. A critical realist epistemological stance will be adopted in this study. The data from the results and discussions of the included qualitative studies will be imported in entirety into NVivo software. These data will be coded line-by-line by two reviewers (YH and RC-T). A coding structure will be agreed on by the two reviewers, compared across studies, and added to as needed. Codes will be grouped into a thematic tree structure. The coding and thematic analysis will be reviewed by two other members of the review team (AMD and RD). Analytical themes will be generated from this independently by YH and RC-T to answer our review objectives before a final analysis is agreed.

Integration of evidence

In this mixed-methods synthesis, qualitative findings contextualise and complement the quantitative results. The findings of the quantitative and qualitative syntheses will be compared and contrasted. Depending on the outcome, the results will be presented as configured analysis or narrative analysis. The integration of opinion and grey literature will be separately reported. The Grading of Recommendations Assessment, Development, and Evaluation will be used to assess evidence quality where appropriate.81

Terminology relating to sex and gender will be reported as per the original paper. The results paper will adhere to the Sex and Gender Equity in Research (SAGER) guidelines.82

Discussion

The mixed-methods systematic review protocol described here aims to synthesise what is currently known about integrating mental healthcare in the treatment of gynaecological illness or during reproductive hormone transitions outside the perinatal period. The incorporation of both quantitative and qualitative research will demonstrate the wider service-level clinical need for integrated care and the human impact of these gaps. The main limitations of this review will likely lie in the limited number and heterogeneity of studies on this topic; hence, it will be unlikely to be possible to conduct a meta-analysis of the included articles. Only studies in English will be included due to limited resources, so some relevant studies may be excluded. The inclusion of opinion and grey literature will supplement the available empirical data, but will be separately reported. The data synthesis will be guided by validated guidelines to achieve methodological rigour: PRISMA, SWiM and ENTREQ. The use of two independent reviewers in the screening, selection, data extraction, quality appraisal and synthesis processes will strengthen the validity of our results. This review aims to guide current service delivery in women’s mental health and inform future service and policy development to better meet the needs of this patient cohort.

Patient and public involvement

There will be no patient or public involvement in the current study.

Ethics and dissemination

Ethical approval is not required for this systematic review, as no primary data will be collected. The results will be disseminated via a peer-reviewed publication in a relevant scientific journal, through oral or poster presentations at national or international academic conferences, at presentations to national policymakers such as the Women’s Health Taskforce in the Republic of Ireland, and to other interested groups via social media. This review will also form part of a doctoral thesis by the author YH. The dataset generated from this synthesis will be made available by the study authors on request.

supplementary material

online supplemental file 1
bmjopen-14-10-s001.doc (114.5KB, doc)
DOI: 10.1136/bmjopen-2024-091378
online supplemental file 2
bmjopen-14-10-s002.pdf (63.6KB, pdf)
DOI: 10.1136/bmjopen-2024-091378

Footnotes

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2024-091378).

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Not applicable.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting or dissemination plans of this research.

Contributor Information

Yvonne Hartnett, Email: hartnety@tcd.ie.

Rebecca Conlan-Trant, Email: conlantr@tcd.ie.

Richard Duffy, Email: rduffy@rotunda.ie.

Anne M Doherty, Email: anne.doherty@ucd.ie.

References

  • 1.WHO . Geneva:: World Health Organisation; 2015. WHO global strategy on people-centred and integrated health services. [Google Scholar]
  • 2.Dublin:: Department of Health; 2017. Committee on the future of healthcare. [Google Scholar]
  • 3.Department of Health . Dublin:: Department of Health; 2020. Sharing the vision: a mental health policy for everyone. [Google Scholar]
  • 4.National Office of Mental Health Engagement and Recovery The experiences of women engaging with mental health services. 2023. https://www.hse.ie/eng/services/list/4/mental-health-services/mental-health-engagement-and-recovery/resources-information-and-publications/mental-health-services-report.pdf Available.
  • 5.Zaks N, Batuure A, Lin E, et al. Association Between Mental Health and Reproductive System Disorders in Women: A Systematic Review and Meta-analysis. JAMA Netw Open . 2023;6:e238685. doi: 10.1001/jamanetworkopen.2023.8685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pope CJ, Sharma V, Sharma S, et al. A Systematic Review of the Association Between Psychiatric Disturbances and Endometriosis. J Obstet Gynaecol Can. 2015;37:1006–15. doi: 10.1016/s1701-2163(16)30050-0. [DOI] [PubMed] [Google Scholar]
  • 7.Laganà AS, La Rosa VL, Rapisarda AMC, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017;9:323–30. doi: 10.2147/IJWH.S119729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Laganà AS, Condemi I, Retto G, et al. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2015;194:30–3. doi: 10.1016/j.ejogrb.2015.08.015. [DOI] [PubMed] [Google Scholar]
  • 9.Lorençatto C, Petta CA, Navarro MJ, et al. Depression in women with endometriosis with and without chronic pelvic pain. Acta Obstet Gynecol Scand. 2006;85:88–92. doi: 10.1080/00016340500456118. [DOI] [PubMed] [Google Scholar]
  • 10.Gambadauro P, Carli V, Hadlaczky G. Depressive symptoms among women with endometriosis: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019;220:230–41. doi: 10.1016/j.ajog.2018.11.123. [DOI] [PubMed] [Google Scholar]
  • 11.Sepulcri R de P, do Amaral VF. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009;142:53–6. doi: 10.1016/j.ejogrb.2008.09.003. [DOI] [PubMed] [Google Scholar]
  • 12.van Barneveld E, Manders J, van Osch FHM, et al. Depression, Anxiety, and Correlating Factors in Endometriosis: A Systematic Review and Meta-Analysis. J Womens Health (Larchmt) 2022;31:219–30. doi: 10.1089/jwh.2021.0021. [DOI] [PubMed] [Google Scholar]
  • 13.Wang Y, Li B, Zhou Y, et al. Does Endometriosis Disturb Mental Health and Quality of Life? A Systematic Review and Meta-Analysis. Gynecol Obstet Invest. 2021;86:315–35. doi: 10.1159/000516517. [DOI] [PubMed] [Google Scholar]
  • 14.Facchin F, Barbara G, Saita E, et al. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol. 2015;36:135–41. doi: 10.3109/0167482X.2015.1074173. [DOI] [PubMed] [Google Scholar]
  • 15.Facchin F, Barbara G, Dridi D, et al. Mental health in women with endometriosis: searching for predictors of psychological distress. Hum Reprod. 2017;32:1855–61. doi: 10.1093/humrep/dex249. [DOI] [PubMed] [Google Scholar]
  • 16.Vannuccini S, Lazzeri L, Orlandini C, et al. Mental health, pain symptoms and systemic comorbidities in women with endometriosis: a cross-sectional study. J Psychosom Obstet Gynaecol. 2018;39:315–20. doi: 10.1080/0167482x.2017.1386171. [DOI] [PubMed] [Google Scholar]
  • 17.Warzecha D, Szymusik I, Wielgos M, et al. The Impact of Endometriosis on the Quality of Life and the Incidence of Depression-A Cohort Study. Int J Environ Res Public Health. 2020;17 doi: 10.3390/ijerph17103641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chen L-C, Hsu J-W, Huang K-L, et al. Risk of developing major depression and anxiety disorders among women with endometriosis: A longitudinal follow-up study. J Affect Disord. 2016;190:282–5. doi: 10.1016/j.jad.2015.10.030. [DOI] [PubMed] [Google Scholar]
  • 19.Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol. 2006;11:613–25. doi: 10.1177/1359105306065021. [DOI] [PubMed] [Google Scholar]
  • 20.Damone AL, Joham AE, Loxton D, et al. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019;49:1510–20. doi: 10.1017/s0033291718002076. [DOI] [PubMed] [Google Scholar]
  • 21.Balikci A, Erdem M, Keskin U, et al. Depression, Anxiety, and Anger in Patients with Polycystic Ovary Syndrome. Noro Psikiyatr Ars. 2014;51:328–33. doi: 10.5152/npa.2014.6898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Almeshari WK, Alsubaie AK, Alanazi RI, et al. Depressive and Anxiety Symptom Assessment in Adults with Polycystic Ovarian Syndrome. Depress Res Treat. 2021;2021:6652133. doi: 10.1155/2021/6652133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Elsenbruch S, Benson S, Hahn S, et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod. 2006;21:1092–9. doi: 10.1093/humrep/dei409. [DOI] [PubMed] [Google Scholar]
  • 24.Dokras A, Clifton S, Futterweit W, et al. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011;117:145–52. doi: 10.1097/AOG.0b013e318202b0a4. [DOI] [PubMed] [Google Scholar]
  • 25.Tan J, Wang Q-Y, Feng G-M, et al. Increased Risk of Psychiatric Disorders in Women with Polycystic Ovary Syndrome in Southwest China. Chin Med J (Engl) 2017;130:262–6. doi: 10.4103/0366-6999.198916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Scaruffi E, Gambineri A, Cattaneo S, et al. Personality and psychiatric disorders in women affected by polycystic ovary syndrome. Front Endocrinol (Lausanne) 2014;5:185. doi: 10.3389/fendo.2014.00185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.McCluskey S, Evans C, Lacey JH, et al. Polycystic ovary syndrome and bulimia. Fertil Steril. 1991;55:287–91. [PubMed] [Google Scholar]
  • 28.Steegers-Theunissen RPM, Wiegel RE, Jansen PW, et al. Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence. Int J Mol Sci. 2020;21:8211. doi: 10.3390/ijms21218211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Cesta CE, Månsson M, Palm C, et al. Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology. 2016;73:196–203. doi: 10.1016/j.psyneuen.2016.08.005. [DOI] [PubMed] [Google Scholar]
  • 30.Rassi A, Veras AB, dos Reis M, et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry. 2010;51:599–602. doi: 10.1016/j.comppsych.2010.02.009. [DOI] [PubMed] [Google Scholar]
  • 31.Yin X, Ji Y, Chan CLW, et al. The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis. Arch Womens Ment Health. 2021;24:11–27. doi: 10.1007/s00737-020-01043-x. [DOI] [PubMed] [Google Scholar]
  • 32.Brutocao C, Zaiem F, Alsawas M, et al. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018;62:318–25. doi: 10.1007/s12020-018-1692-3. [DOI] [PubMed] [Google Scholar]
  • 33.Li N, Yuan M, Li Q, et al. Higher Risk of Anxiety and Depression in Women with Adenomyosis as Compared with Those with Uterine Leiomyoma. JCM. 2022;11:2638. doi: 10.3390/jcm11092638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Osório FL, Carvalho ACF, Donadon MF, et al. Chronic pelvic pain, psychiatric disorders and early emotional traumas: Results of a cross sectional case-control study. World J Psychiatry. 2016;6:339–44. doi: 10.5498/wjp.v6.i3.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Brünahl C, Dybowski C, Albrecht R, et al. Mental disorders in patients with chronic pelvic pain syndrome (CPPS) J Psychosom Res. 2017;98:19–26. doi: 10.1016/j.jpsychores.2017.04.011. [DOI] [PubMed] [Google Scholar]
  • 36.Miller-Matero LR, Saulino C, Clark S, et al. When treating the pain is not enough: a multidisciplinary approach for chronic pelvic pain. Arch Womens Ment Health. 2016;19:349–54. doi: 10.1007/s00737-015-0537-9. [DOI] [PubMed] [Google Scholar]
  • 37.Bryant C, Cockburn R, Plante A-F, et al. The psychological profile of women presenting to a multidisciplinary clinic for chronic pelvic pain: high levels of psychological dysfunction and implications for practice. J Pain Res. 2016;9:1049–56. doi: 10.2147/JPR.S115065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Magariños López M, Lobato Rodríguez MJ, Menéndez García Á, et al. Psychological Profile in Women with Chronic Pelvic Pain. J Clin Med. 2022;11:6345. doi: 10.3390/jcm11216345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Robinson MJ, Edwards SE, Iyengar S, et al. Depression and pain. Front Biosci (Landmark Ed) 2009;14:5031–51. doi: 10.2741/3585. [DOI] [PubMed] [Google Scholar]
  • 40.Raglan GB, Schulkin J, Micks E. Depression during perimenopause: the role of the obstetrician-gynecologist. Arch Womens Ment Health. 2020;23:1–10. doi: 10.1007/s00737-019-0950-6. [DOI] [PubMed] [Google Scholar]
  • 41.Suau GM, Normandia R, Rodriguez R, et al. Depressive symptoms and risk factors among perimenopausal women. P R Health Sci J. 2005;24:207–10. [PubMed] [Google Scholar]
  • 42.Bromberger JT, Meyer PM, Kravitz HM, et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health. 2001;91:1435–42. doi: 10.2105/ajph.91.9.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61:62–70. doi: 10.1001/archpsyc.61.1.62. [DOI] [PubMed] [Google Scholar]
  • 44.Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63:385–90. doi: 10.1001/archpsyc.63.4.385. [DOI] [PubMed] [Google Scholar]
  • 45.Association AP. Diagnostic and Statistical Manual of Mental Disorders. Arlington: American Psychiatric Publishing; 2013. [Google Scholar]
  • 46.Epperson CN, Steiner M, Hartlage SA, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry. 2012;169:465–75. doi: 10.1176/appi.ajp.2012.11081302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wittchen H-U, Becker E, Lieb R, et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32:119–32. doi: 10.1017/s0033291701004925. [DOI] [PubMed] [Google Scholar]
  • 48.Hantsoo L, Epperson CN. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep. 2015;17:87. doi: 10.1007/s11920-015-0628-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Kuehner C, Nayman S. Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps. Curr Psychiatry Rep. 2021;23:78. doi: 10.1007/s11920-021-01286-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Osborn E, Brooks J, O’Brien PMS, et al. Suicidality in women with Premenstrual Dysphoric Disorder: a systematic literature review. Arch Womens Ment Health. 2021;24:173–84. doi: 10.1007/s00737-020-01054-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Yan H, Ding Y, Guo W. Suicidality in patients with premenstrual dysphoric disorder-A systematic review and meta-analysis. J Affect Disord. 2021;295:339–46. doi: 10.1016/j.jad.2021.08.082. [DOI] [PubMed] [Google Scholar]
  • 52.Prasad D, Wollenhaupt-Aguiar B, Kidd KN, et al. Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis. J Womens Health (Larchmt) 2021;30:1693–707. doi: 10.1089/jwh.2021.0185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Rogers A, Obst S, Teague SJ, et al. Association Between Maternal Perinatal Depression and Anxiety and Child and Adolescent Development: A Meta-analysis. JAMA Pediatr. 2020;174:1082–92. doi: 10.1001/jamapediatrics.2020.2910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Glover V, O’Donnell KJ, O’Connor TG, et al. Prenatal maternal stress, fetal programming, and mechanisms underlying later psychopathology-A global perspective. Dev Psychopathol. 2018;30:843–54. doi: 10.1017/S095457941800038X. [DOI] [PubMed] [Google Scholar]
  • 55.Langham J, Gurol-Urganci I, Muller P, et al. Obstetric and neonatal outcomes in pregnant women with and without a history of specialist mental health care: a national population-based cohort study using linked routinely collected data in England. Lancet Psychiatry. 2023;10:748–59. doi: 10.1016/S2215-0366(23)00200-6. [DOI] [PubMed] [Google Scholar]
  • 56.NHS . National Health Service; 2016. Implementing the five year foward view for mental health.https://www.england.nhs.uk/wp-content/uploads/2016/07/fyfv-mh.pdf Available. [Google Scholar]
  • 57.HSE Specialist perinatal mental health services: model of care for Ireland. Health Service Executive. 2016. https://www.hse.ie/eng/services/list/4/mental-health-services/specialist-perinatal-mental-health/specialist-perinatal-mental-health-services-model-of-care-2017.pdf Available.
  • 58.RANZP Position statement: perinatal mental health services. Royal Australian & New Zealand College of Psychiatrists. 2021. https://www.ranzcp.org/clinical-guidelines-publications/clinical-guidelines-publications-library/perinatal-mental-health-services Available.
  • 59.Griffen A, McIntyre L, Belsito JZ, et al. Perinatal Mental Health Care In The United States: An Overview Of Policies And Programs. Health Aff (Millwood) 2021;40:1543–50. doi: 10.1377/hlthaff.2021.00796. [DOI] [PubMed] [Google Scholar]
  • 60.Hicks LM, Ou C, Charlebois J, et al. Assessment of Canadian perinatal mental health services from the provider perspective: Where can we improve? Front Psychiatry. 2022;13:929496. doi: 10.3389/fpsyt.2022.929496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Moore Simas TA, Flynn MP, Kroll-Desrosiers AR, et al. A Systematic Review of Integrated Care Interventions Addressing Perinatal Depression Care in Ambulatory Obstetric Care Settings. Clin Obstet Gynecol. 2018;61:573–90. doi: 10.1097/GRF.0000000000000360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Tachibana Y, Koizumi N, Akanuma C, et al. Integrated mental health care in a multidisciplinary maternal and child health service in the community: the findings from the Suzaka trial. BMC Pregnancy Childbirth. 2019;19:58. doi: 10.1186/s12884-019-2179-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Howard LM, Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry. 2020;19:313–27. doi: 10.1002/wps.20769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. doi: 10.1136/bmj.g7647. [DOI] [PubMed] [Google Scholar]
  • 65.Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Tong A, Flemming K, McInnes E, et al. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12:181. doi: 10.1186/1471-2288-12-181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. doi: 10.1136/bmj.l6890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Lizarondo L, Stern C, Carrier J, et al. JBI Manual for Evidence Synthesis. JBI; 2020. Chapter 8: mixed methods systematic reviews. Available. [DOI] [Google Scholar]
  • 69.Hartnett Y, Conlan-Trant R, Duffy R, et al. Cross-disciplinary working between gynaecologists and mental healthcare professionals: a mixed-methods systematic review protocol. PROSPERO. 2024. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024523590 Available. [DOI] [PMC free article] [PubMed]
  • 70.Philadelphia, PA: Clarivate; 2013. Endnote [program] [Google Scholar]
  • 71.Melbourne, Australia:: Veritas Health Innovation; 2024. Covidence systematic review software [program] [Google Scholar]
  • 72.Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. doi: 10.1136/bmj.g1687. [DOI] [PubMed] [Google Scholar]
  • 73.Lockwood C, Porritt K, Munn Z, et al. In: JBI Manual for Evidence Synthesis. Aromataris E, Munn Z, editors. JBI; Chapter 2: systematic reviews of qualitative evidence. Available. [DOI] [Google Scholar]
  • 74.NVivo [program] 2017. www.lumivero.com Available.
  • 75.McArthur A, Klugarova J, Yan H. In: JBI reviewer’s manual. Aromataris E, Munn Z, editors. JBI; 2020. Chapter 4: systematic reviews of text and opinion.https://reviewersmanual.joannabriggs.org/ Available. [Google Scholar]
  • 76.ROBINS-E Development Group Risk of bias in non-randomized studies - of exposure (ROBINS-E) 2023
  • 77.Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898. [DOI] [PubMed] [Google Scholar]
  • 78.Programme CAS CASP checklist: 10 questions to help you make sense of a qualitative research. 2023. https://casp-uk.net/images/checklist/documents/CASP-Qualitative-Studies-Checklist/CASP-Qualitative-Checklist-2018_fillable_form.pdf Available.
  • 79.Tyndall J. AACODS Checklist. Flinders University. 2010. [24-Feb-2024]. http://dspace.flinders.edu.au/dspace/ Available. Accessed.
  • 80.Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. doi: 10.1186/1471-2288-8-45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94. doi: 10.1016/j.jclinepi.2010.04.026. [DOI] [PubMed] [Google Scholar]
  • 82.Heidari S, Babor TF, De Castro P, et al. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev. 2016;1:2. doi: 10.1186/s41073-016-0007-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    online supplemental file 1
    bmjopen-14-10-s001.doc (114.5KB, doc)
    DOI: 10.1136/bmjopen-2024-091378
    online supplemental file 2
    bmjopen-14-10-s002.pdf (63.6KB, pdf)
    DOI: 10.1136/bmjopen-2024-091378

    Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

    RESOURCES